Report cover image

Global AI Image-assisted Diagnosis Software Market Analysis and Forecast 2026-2032

Publisher APO Research, Inc.
Published Jan 06, 2026
Length 195 Pages
SKU # APRC20776421

Description

The global AI Image-assisted Diagnosis Software market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for AI Image-assisted Diagnosis Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for AI Image-assisted Diagnosis Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Asia-Pacific market for AI Image-assisted Diagnosis Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for AI Image-assisted Diagnosis Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of AI Image-assisted Diagnosis Software include KONFOONG BIOTECH INTERNATIONAL CO., LTD(KFBIO), Solvision, IBM Watson, Butterfly Network, Arterys, Zebra Medical Vision, Freenome, MIT Technology Review and Lunit, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes


This report presents an overview of global market for AI Image-assisted Diagnosis Software, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of AI Image-assisted Diagnosis Software, also provides the revenue of main regions and countries. Of the upcoming market potential for AI Image-assisted Diagnosis Software, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the AI Image-assisted Diagnosis Software revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global AI Image-assisted Diagnosis Software market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for AI Image-assisted Diagnosis Software revenue, projected growth trends, production technology, application and end-user industry.


AI Image-assisted Diagnosis Software Segment by Company

KONFOONG BIOTECH INTERNATIONAL CO., LTD(KFBIO)
Solvision
IBM Watson
Butterfly Network
Arterys
Zebra Medical Vision
Freenome
MIT Technology Review
Lunit
DiA Imaging
RetinAi
Subtle Medical
BrainMiner

AI Image-assisted Diagnosis Software Segment by Type

Ultrasound Image
Radiographic Image
Radiation Therapy
Pathological Analysis
Endoscopic Image

AI Image-assisted Diagnosis Software Segment by Application

Hospital
Ambulatory Surgery Center

AI Image-assisted Diagnosis Software Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI Image-assisted Diagnosis Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of AI Image-assisted Diagnosis Software and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI Image-assisted Diagnosis Software.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of AI Image-assisted Diagnosis Software in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of AI Image-assisted Diagnosis Software company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, AI Image-assisted Diagnosis Software revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

195 Pages
1 Market Overview
1.1 Product Definition
1.2 AI Image-assisted Diagnosis Software Market by Type
1.2.1 Global AI Image-assisted Diagnosis Software Market Size by Type, 2021 VS 2025 VS 2032
1.2.2 Ultrasound Image
1.2.3 Radiographic Image
1.2.4 Radiation Therapy
1.2.5 Pathological Analysis
1.2.6 Endoscopic Image
1.3 AI Image-assisted Diagnosis Software Market by Application
1.3.1 Global AI Image-assisted Diagnosis Software Market Size by Application, 2021 VS 2025 VS 2032
1.3.2 Hospital
1.3.3 Ambulatory Surgery Center
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 AI Image-assisted Diagnosis Software Market Dynamics
2.1 AI Image-assisted Diagnosis Software Industry Trends
2.2 AI Image-assisted Diagnosis Software Industry Drivers
2.3 AI Image-assisted Diagnosis Software Industry Opportunities and Challenges
2.4 AI Image-assisted Diagnosis Software Industry Restraints
3 Global Growth Perspective
3.1 Global AI Image-assisted Diagnosis Software Market Perspective (2021-2032)
3.2 Global AI Image-assisted Diagnosis Software Growth Trends by Region
3.2.1 Global AI Image-assisted Diagnosis Software Market Size by Region: 2021 VS 2025 VS 2032
3.2.2 Global AI Image-assisted Diagnosis Software Market Size by Region (2021-2026)
3.2.3 Global AI Image-assisted Diagnosis Software Market Size by Region (2027-2032)
4 Competitive Landscape by Players
4.1 Global AI Image-assisted Diagnosis Software Revenue by Players
4.1.1 Global AI Image-assisted Diagnosis Software Revenue by Players (2021-2026)
4.1.2 Global AI Image-assisted Diagnosis Software Revenue Market Share by Players (2021-2026)
4.1.3 Global AI Image-assisted Diagnosis Software Players Revenue Share Top 10 and Top 5 in 2025
4.2 Global AI Image-assisted Diagnosis Software Key Players Ranking, 2024 VS 2025 VS 2026
4.3 Global AI Image-assisted Diagnosis Software Key Players Headquarters & Area Served
4.4 Global AI Image-assisted Diagnosis Software Players, Product Type & Application
4.5 Global AI Image-assisted Diagnosis Software Players Establishment Date
4.6 Market Competitive Analysis
4.6.1 Global AI Image-assisted Diagnosis Software Market CR5 and HHI
4.6.3 2025 AI Image-assisted Diagnosis Software Tier 1, Tier 2, and Tier 3
5 AI Image-assisted Diagnosis Software Market Size by Type
5.1 Global AI Image-assisted Diagnosis Software Revenue by Type (2021 VS 2025 VS 2032)
5.2 Global AI Image-assisted Diagnosis Software Revenue by Type (2021-2032)
5.3 Global AI Image-assisted Diagnosis Software Revenue Market Share by Type (2021-2032)
6 AI Image-assisted Diagnosis Software Market Size by Application
6.1 Global AI Image-assisted Diagnosis Software Revenue by Application (2021 VS 2025 VS 2032)
6.2 Global AI Image-assisted Diagnosis Software Revenue by Application (2021-2032)
6.3 Global AI Image-assisted Diagnosis Software Revenue Market Share by Application (2021-2032)
7 Company Profiles
7.1 KONFOONG BIOTECH INTERNATIONAL CO., LTD(KFBIO)
7.1.1 KONFOONG BIOTECH INTERNATIONAL CO., LTD(KFBIO) Company Information
7.1.2 KONFOONG BIOTECH INTERNATIONAL CO., LTD(KFBIO) Business Overview
7.1.3 KONFOONG BIOTECH INTERNATIONAL CO., LTD(KFBIO) AI Image-assisted Diagnosis Software Revenue and Gross Margin (2021-2026)
7.1.4 KONFOONG BIOTECH INTERNATIONAL CO., LTD(KFBIO) AI Image-assisted Diagnosis Software Product Portfolio
7.1.5 KONFOONG BIOTECH INTERNATIONAL CO., LTD(KFBIO) Recent Developments
7.2 Solvision
7.2.1 Solvision Company Information
7.2.2 Solvision Business Overview
7.2.3 Solvision AI Image-assisted Diagnosis Software Revenue and Gross Margin (2021-2026)
7.2.4 Solvision AI Image-assisted Diagnosis Software Product Portfolio
7.2.5 Solvision Recent Developments
7.3 IBM Watson
7.3.1 IBM Watson Company Information
7.3.2 IBM Watson Business Overview
7.3.3 IBM Watson AI Image-assisted Diagnosis Software Revenue and Gross Margin (2021-2026)
7.3.4 IBM Watson AI Image-assisted Diagnosis Software Product Portfolio
7.3.5 IBM Watson Recent Developments
7.4 Butterfly Network
7.4.1 Butterfly Network Company Information
7.4.2 Butterfly Network Business Overview
7.4.3 Butterfly Network AI Image-assisted Diagnosis Software Revenue and Gross Margin (2021-2026)
7.4.4 Butterfly Network AI Image-assisted Diagnosis Software Product Portfolio
7.4.5 Butterfly Network Recent Developments
7.5 Arterys
7.5.1 Arterys Company Information
7.5.2 Arterys Business Overview
7.5.3 Arterys AI Image-assisted Diagnosis Software Revenue and Gross Margin (2021-2026)
7.5.4 Arterys AI Image-assisted Diagnosis Software Product Portfolio
7.5.5 Arterys Recent Developments
7.6 Zebra Medical Vision
7.6.1 Zebra Medical Vision Company Information
7.6.2 Zebra Medical Vision Business Overview
7.6.3 Zebra Medical Vision AI Image-assisted Diagnosis Software Revenue and Gross Margin (2021-2026)
7.6.4 Zebra Medical Vision AI Image-assisted Diagnosis Software Product Portfolio
7.6.5 Zebra Medical Vision Recent Developments
7.7 Freenome
7.7.1 Freenome Company Information
7.7.2 Freenome Business Overview
7.7.3 Freenome AI Image-assisted Diagnosis Software Revenue and Gross Margin (2021-2026)
7.7.4 Freenome AI Image-assisted Diagnosis Software Product Portfolio
7.7.5 Freenome Recent Developments
7.8 MIT Technology Review
7.8.1 MIT Technology Review Company Information
7.8.2 MIT Technology Review Business Overview
7.8.3 MIT Technology Review AI Image-assisted Diagnosis Software Revenue and Gross Margin (2021-2026)
7.8.4 MIT Technology Review AI Image-assisted Diagnosis Software Product Portfolio
7.8.5 MIT Technology Review Recent Developments
7.9 Lunit
7.9.1 Lunit Company Information
7.9.2 Lunit Business Overview
7.9.3 Lunit AI Image-assisted Diagnosis Software Revenue and Gross Margin (2021-2026)
7.9.4 Lunit AI Image-assisted Diagnosis Software Product Portfolio
7.9.5 Lunit Recent Developments
7.10 DiA Imaging
7.10.1 DiA Imaging Company Information
7.10.2 DiA Imaging Business Overview
7.10.3 DiA Imaging AI Image-assisted Diagnosis Software Revenue and Gross Margin (2021-2026)
7.10.4 DiA Imaging AI Image-assisted Diagnosis Software Product Portfolio
7.10.5 DiA Imaging Recent Developments
7.11 RetinAi
7.11.1 RetinAi Company Information
7.11.2 RetinAi Business Overview
7.11.3 RetinAi AI Image-assisted Diagnosis Software Revenue and Gross Margin (2021-2026)
7.11.4 RetinAi AI Image-assisted Diagnosis Software Product Portfolio
7.11.5 RetinAi Recent Developments
7.12 Subtle Medical
7.12.1 Subtle Medical Company Information
7.12.2 Subtle Medical Business Overview
7.12.3 Subtle Medical AI Image-assisted Diagnosis Software Revenue and Gross Margin (2021-2026)
7.12.4 Subtle Medical AI Image-assisted Diagnosis Software Product Portfolio
7.12.5 Subtle Medical Recent Developments
7.13 BrainMiner
7.13.1 BrainMiner Company Information
7.13.2 BrainMiner Business Overview
7.13.3 BrainMiner AI Image-assisted Diagnosis Software Revenue and Gross Margin (2021-2026)
7.13.4 BrainMiner AI Image-assisted Diagnosis Software Product Portfolio
7.13.5 BrainMiner Recent Developments
8 North America
8.1 North America AI Image-assisted Diagnosis Software Revenue (2021-2032)
8.2 North America AI Image-assisted Diagnosis Software Revenue by Type (2021-2032)
8.2.1 North America AI Image-assisted Diagnosis Software Revenue by Type (2021-2026)
8.2.2 North America AI Image-assisted Diagnosis Software Revenue by Type (2027-2032)
8.3 North America AI Image-assisted Diagnosis Software Revenue Share by Type (2021-2032)
8.4 North America AI Image-assisted Diagnosis Software Revenue by Application (2021-2032)
8.4.1 North America AI Image-assisted Diagnosis Software Revenue by Application (2021-2026)
8.4.2 North America AI Image-assisted Diagnosis Software Revenue by Application (2027-2032)
8.5 North America AI Image-assisted Diagnosis Software Revenue Share by Application (2021-2032)
8.6 North America AI Image-assisted Diagnosis Software Revenue by Country
8.6.1 North America AI Image-assisted Diagnosis Software Revenue by Country (2021 VS 2025 VS 2032)
8.6.2 North America AI Image-assisted Diagnosis Software Revenue by Country (2021-2026)
8.6.3 North America AI Image-assisted Diagnosis Software Revenue by Country (2027-2032)
8.6.4 United States
8.6.5 Canada
8.6.6 Mexico
9 Europe
9.1 Europe AI Image-assisted Diagnosis Software Revenue (2021-2032)
9.2 Europe AI Image-assisted Diagnosis Software Revenue by Type (2021-2032)
9.2.1 Europe AI Image-assisted Diagnosis Software Revenue by Type (2021-2026)
9.2.2 Europe AI Image-assisted Diagnosis Software Revenue by Type (2027-2032)
9.3 Europe AI Image-assisted Diagnosis Software Revenue Share by Type (2021-2032)
9.4 Europe AI Image-assisted Diagnosis Software Revenue by Application (2021-2032)
9.4.1 Europe AI Image-assisted Diagnosis Software Revenue by Application (2021-2026)
9.4.2 Europe AI Image-assisted Diagnosis Software Revenue by Application (2027-2032)
9.5 Europe AI Image-assisted Diagnosis Software Revenue Share by Application (2021-2032)
9.6 Europe AI Image-assisted Diagnosis Software Revenue by Country
9.6.1 Europe AI Image-assisted Diagnosis Software Revenue by Country (2021 VS 2025 VS 2032)
9.6.2 Europe AI Image-assisted Diagnosis Software Revenue by Country (2021-2026)
9.6.3 Europe AI Image-assisted Diagnosis Software Revenue by Country (2027-2032)
9.6.4 Germany
9.6.5 France
9.6.6 U.K.
9.6.7 Italy
9.6.8 Russia
9.6.9 Spain
9.6.10 Netherlands
9.6.11 Switzerland
9.6.12 Sweden
9.6.13 Poland
10 China
10.1 China AI Image-assisted Diagnosis Software Revenue (2021-2032)
10.2 China AI Image-assisted Diagnosis Software Revenue by Type (2021-2032)
10.2.1 China AI Image-assisted Diagnosis Software Revenue by Type (2021-2026)
10.2.2 China AI Image-assisted Diagnosis Software Revenue by Type (2027-2032)
10.3 China AI Image-assisted Diagnosis Software Revenue Share by Type (2021-2032)
10.4 China AI Image-assisted Diagnosis Software Revenue by Application (2021-2032)
10.4.1 China AI Image-assisted Diagnosis Software Revenue by Application (2021-2026)
10.4.2 China AI Image-assisted Diagnosis Software Revenue by Application (2027-2032)
10.5 China AI Image-assisted Diagnosis Software Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
11.1 Asia AI Image-assisted Diagnosis Software Revenue (2021-2032)
11.2 Asia AI Image-assisted Diagnosis Software Revenue by Type (2021-2032)
11.2.1 Asia AI Image-assisted Diagnosis Software Revenue by Type (2021-2026)
11.2.2 Asia AI Image-assisted Diagnosis Software Revenue by Type (2027-2032)
11.3 Asia AI Image-assisted Diagnosis Software Revenue Share by Type (2021-2032)
11.4 Asia AI Image-assisted Diagnosis Software Revenue by Application (2021-2032)
11.4.1 Asia AI Image-assisted Diagnosis Software Revenue by Application (2021-2026)
11.4.2 Asia AI Image-assisted Diagnosis Software Revenue by Application (2027-2032)
11.5 Asia AI Image-assisted Diagnosis Software Revenue Share by Application (2021-2032)
11.6 Asia AI Image-assisted Diagnosis Software Revenue by Country
11.6.1 Asia AI Image-assisted Diagnosis Software Revenue by Country (2021 VS 2025 VS 2032)
11.6.2 Asia AI Image-assisted Diagnosis Software Revenue by Country (2021-2026)
11.6.3 Asia AI Image-assisted Diagnosis Software Revenue by Country (2027-2032)
11.6.4 Japan
11.6.5 South Korea
11.6.6 India
11.6.7 Australia
11.6.8 Taiwan
11.6.9 Southeast Asia
12 South America, Middle East and Africa
12.1 SAMEA AI Image-assisted Diagnosis Software Revenue (2021-2032)
12.2 SAMEA AI Image-assisted Diagnosis Software Revenue by Type (2021-2032)
12.2.1 SAMEA AI Image-assisted Diagnosis Software Revenue by Type (2021-2026)
12.2.2 SAMEA AI Image-assisted Diagnosis Software Revenue by Type (2027-2032)
12.3 SAMEA AI Image-assisted Diagnosis Software Revenue Share by Type (2021-2032)
12.4 SAMEA AI Image-assisted Diagnosis Software Revenue by Application (2021-2032)
12.4.1 SAMEA AI Image-assisted Diagnosis Software Revenue by Application (2021-2026)
12.4.2 SAMEA AI Image-assisted Diagnosis Software Revenue by Application (2027-2032)
12.5 SAMEA AI Image-assisted Diagnosis Software Revenue Share by Application (2021-2032)
12.6 SAMEA AI Image-assisted Diagnosis Software Revenue by Country
12.6.1 SAMEA AI Image-assisted Diagnosis Software Revenue by Country (2021 VS 2025 VS 2032)
12.6.2 SAMEA AI Image-assisted Diagnosis Software Revenue by Country (2021-2026)
12.6.3 SAMEA AI Image-assisted Diagnosis Software Revenue by Country (2027-2032)
12.6.4 Brazil
12.6.5 Argentina
12.6.6 Chile
12.6.7 Colombia
12.6.8 Peru
12.6.9 Saudi Arabia
12.6.10 Israel
12.6.11 UAE
12.6.12 Turkey
12.6.13 Iran
12.6.14 Egypt
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.